// App-Quantinova.ai

332.0 : A preclinical trial to evaluate therapies for BRCA-associated pancreatic cancer.

Researchers

Presenter

  • Jin Yong Patrick Park

Principal Investigators

  • Anita Hall

  • David W. Hedley

  • Ming Sound Tsao

  • Steven Gallinger

  • George Zogopoulos

Medical Centers

  • Montreal University, Montreal, QC, Canada

  • McGill University Health Centre, Montreal, QC, Canada

  • Ontario Cancer Institute, Princess Margaret Hospital, Toronto, ON, Canada

  • Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

  • Mount Sinai Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Breast cancer type 1 susceptibility protein

Drug/Treatment

  • Gemcitabine

  • Talazoparib

  • Cisplatin

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved